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The Notch pathway is a highly conserved signaling
system that controls a diversity of growth, differenti-
ation, and patterning processes. In growing blood
vessels, sprouting of endothelial tip cells is inhibited
by Notch signaling, which is activated by binding of
the Notch receptor to its ligand Delta-like 4 (Dll4).
Here, we show that the Notch ligand Jagged1 is
a potent proangiogenic regulator in mice that
antagonizes Dll4-Notch signaling in cells expressing
Fringe family glycosyltransferases. Upon glycosyla-
tion of Notch, Dll4-Notch signaling is enhanced,
whereas Jagged1 has weak signaling capacity and
competes with Dll4. Our findings establish that the
equilibrium between two Notch ligands with distinct
spatial expression patterns and opposing functional
roles regulates angiogenesis, a mechanism that
might also apply to other Notch-controlled biological
processes.
INTRODUCTION
During development, growth, or regeneration, the local blood
vessel network expands through angiogenic sprouting into areas
that have demand for nutrients and oxygen. This process is
strongly controlled by hypoxia-dependent, tissue-derived proan-
giogenic signals, such as vascular endothelial growth factor
(VEGF), which binds to cognate receptors in the endothelium
(Carmeliet, 2005; Liao and Johnson, 2007). However, the regula-
tion of endothelial cell (EC) sprouting and proliferation also
involves intrinsic signaling interactions between ECs that are,
for example, mediated by the Notch pathway (Bray, 2006; Roca
and Adams, 2007). The ligand Dll4, a transmembrane protein, is
upregulated by VEGF in the angiogenic vasculature (Hainaud
et al., 2006; Hellstrom et al., 2007; Lobov et al., 2007; Noguera-
Troise et al., 2006; Suchting et al., 2007). High expression of
Dll4 in filopodia-rich endothelial tip cells, which lead and guide
new sprouts, is thought to activate Notch and suppress the tip1124 Cell 137, 1124–1135, June 12, 2009 ª2009 Elsevier Inc.phenotype in adjacent (stalk) ECs. Thus, a sufficient number of
ECs maintains vascular integrity and tissue perfusion. This
activity of Notch is at least partially mediated by downregulation
of VEGF receptor expression, a process that will dampen down
the response to VEGF and suppress sprouting by stalk ECs
(Harrington et al., 2008; Hellstrom et al., 2007; Ridgway et al.,
2006; Suchting et al., 2007). The delicate nature of this balance
is uncovered in mice lacking a single Dll4 allele or by interfering
with Dll4 or Notch function in mice (Hellstrom et al., 2007; Lobov
et al., 2007; Suchting et al., 2007), zebrafish (Leslie et al., 2007;
Siekmann and Lawson, 2007), or in experimental tumors (Li
et al., 2007; Noguera-Troise et al., 2006; Ridgway et al., 2006).
In all these models, more ECs extend filopodial protrusions and
sprout toward the angiogenic stimulus. In experimental tumors,
Dll4 inhibition leads to excessive sprouting from intratumor blood
vessels, which compromises tumor perfusion and growth (Li
et al., 2007; Noguera-Troise et al., 2006).
Here, we have investigated the role of the Notch ligand
Jagged1, a member of the Jagged/Serrate family, in angiogen-
esis. Delta-like or Jagged ligand binding to Notch receptors
triggers the separation of the Notch extracellular domain by
proteases of the ADAM family. Subsequent g-secretase pro-
cessing releases the Notch intracellular domain (NICD), which
translocates into the nucleus and regulates downstream gene
expression (Nichols et al., 2007; Schweisguth, 2004).
Although the important role of Dll4-Notch signaling in the
cardiovascular system is already widely appreciated, we now
show that Jagged1 is a critical positive regulator of tip cell forma-
tion and sprouting because of its ability to modulate Dll4-Notch
signaling in the angiogenic endothelium.
RESULTS
Jagged1 Controls Angiogenesis in the Embryo
Because the global inactivation of the Jagged1 gene (Jag1)
leads to early embryonic lethality (Xue et al., 1999), we have
used EC-specific and inducible genetic approaches in mice.
For loss-of-function studies, mice carrying a loxP-flanked Jag1
gene (Jag1flox/flox) (Brooker et al., 2006) were intercrossed with
Tie1-Cre (Gustafsson et al., 2001) or Pdgfb-iCreER (Claxton
et al., 2008) transgenics, which express in ECs constitutive or
tamoxifen-inducible Cre recombinase, respectively. As previously
shown (Enge et al., 2002), Tie1-Cre mice yielded variable levels of
gene inactivation. The most severely affectedJag1flox/flox Tie1-Cre
(Jag1DEC) mutants died as early as embryonic day 10.5 (E10.5)
and phenocopied a published EC-specific Jag1 knockout (High
et al., 2008), while the others succumbed later. Despite of this vari-
ability, Jag1DEC E17.5 embryos show reduced branching in
dermal vasculature (see Figure S1A available online), suggesting
that Jagged1, like Dll4, controls angiogenesis. We also generated
an inducible and EC-specific gain-of-function model consisting of
mice carrying a murine Jag1 cDNA under control of a tetracycline-
regulated minimal promoter (tetO-Jag1) and VE-Cadherin-tTA
transgenics, which express the tetracyclin-controlled transactiva-
tor (tTA) (Sun et al., 2005). Without tTA transactivator repression,
the resulting mutants (Jag1GOF) die before E16.5. Freshly iso-
lated Jag1GOF embryos at E15.5 show mild growth retardation
and extensive hemorrhaging in the skin. Opposite to the pheno-
Figure 1. Retinal Angiogenesis in EC-Spe-
cific Jagged1 Loss-of-Function Mutants
(A) Diagram illustrating the inducible gene deletion
in retinal ECs. Following tamoxifen administration
from P1 to P3, retinas were analyzed by isolectin
B4 (B–G) and Jagged1 (Jag1) (B–D) whole-mount
immunostaining at P6.
(B, C, and F) Confocal images show decreased
vessel branching and low EC coverage in Jag1iDEC
retinas. Jag1iDEC mutants have some residual
Jagged1 protein (10%–20% of control levels).
(D and E) Compromised branching and growth of
the retinal vasculature in Jag1null/iDEC mutants.
Anti-Jagged1 staining is absent in mutant ECs.
(G) Decreased tip cell and filopodia extension at
the Jag1iDEC angiogenic front.
(H) Quantitation of vascular parameters in the
control and mutant retina as indicated. Error bars
represent s.e.m.; P values are indicated. Scale
bars: B–E: 200 mm; F: 100 mm; G: 25 mm.
type of Jag1DEC loss-of-function mutants,
vessel branching and EC density are
increased in the Jag1GOF dermal vascula-
ture (Figure S1B).
Reduced Sprouting Angiogenesis
in Jag1 Loss-of-Function Mutants
Next, we investigated Jagged1 function in
the retinal vasculature. The retina is avas-
cular at birth, and a single, superficial layer
of blood vessels grows progressively from
the center toward the periphery from
postnatal day (P) 1 until P7 (Figure 1A).
Pdgfb-iCreER transgenics, which target
retinal ECs, including tip and stalk cells
(Claxton et al., 2008) (Figure S2), were
bred into the Jag1flox/flox background.
Following postnatal tamoxifen adminis-
tration, retinas with induced endothelial
Jag1 deletion (Jag1iDEC) display signifi-
cantly decreased vascular branching and EC coverage at P6
(Figures 1A–1C, 1F, and 1H). As Jagged1 is strongly diminished
but not fully absent in Jag1iDEC ECs (Figure 1C), we also
combined loxP-flanked and constitutive null alleles. Pdgfb-
iCreER-mediated Jag1deletion is more efficient in thisJag1null/iDEC
background, and residual protein is absent (Figure 1D). Growth
of the Jag1null/iDEC retinal vasculature is strongly inhibited, result-
ing in reduced branching and delayed extension toward the
periphery (Figures 1D, 1E, and 1H). Consistent with a general
role of Jagged1 in postnatal angiogenesis, Jag1null/iDEC pups
are also generally smaller than tamoxifen-treated control litter-
mates (data not shown).
One hallmark of angiogenesis is the emergence of filopodia-
extending endothelial tip cells, which indicate that ECs have
acquired an exploratory, motile mode (Gerhardt et al., 2003).
The loss of Jagged1 in ECs leads to a significant decrease in
the number of tips and filopodia (Figures 1G and 1H). Moreover,Cell 137, 1124–1135, June 12, 2009 ª2009 Elsevier Inc. 1125
in vivo labeling with 5-bromodeoxyuridine (BrdU) shows that
Jagged1 also positively controls EC proliferation in addition to
sprouting (Figure 2A).
Vessel Stability and Mural Cell Coverage
in Jag1iDEC Mutants
Besides angiogenic defects, decreased vessel stability might
contribute to the reduced vessel density in Jag1iDEC mutants.
Regressing ECs leave empty sleeves of matrix deposits rich in
collagen IV (Baluk et al., 2003). However, we found no overt
change in the number of empty (colIV+ isolectin B4) sleeves
in the Jag1iDEC retina (Figure 2B). Furthermore, Jag1 inactivation
by tamoxifen administration between P5 and P9 confirmed that
the stability of established vessels in the superficial capillary
plexus does not require Jagged1. In contrast, perpendicular
sprouting and neovascularization of the deeper retina, which
occur from P6 onward, are strongly compromised in Jag1iDEC
mutants (Figure 2C).
Since it was shown that endothelial Jagged1 is important for the
recruitment of vascular smooth muscle cells (vSMCs) in the early
embryo (High et al., 2008), we analyzed the coverage of blood
vessels by mural cells, namely vSMCs and pericytes. Analysis
of a-smooth muscle actin-stained P6 retinas revealed decreased
vSMC coverage of Jag1iDEC arteries (Figures 3A–3F), which is,
however, unlikely to cause sprouting defects. Pericytes, which
Figure 2. Jag1 Deletion Compromises EC
Proliferation but Not the Pattern of Estab-
lished Vessels
(A) Isolectin B4 (red) and BrdU labeling (green) of
whole-mount control and Jag1iDEC P6 retinas
(left). Quantitation of BrdU-positive cells shows
reducedEC proliferation inJag1iDECmutants (right).
Error bars represent s.e.m.; P values are indicated.
(B) Whole-mount Isolectin B4 (red) and collagen IV
(green) staining of P6 retinas. The number of
empty (ColIV+ IsolB4) sleeves (arrows) in the
proximal and distal capillary plexus is similar in
control and Jag1iDEC animals.
(C) Diagram of experiments during late retina
vascular development (left). Following tamoxifen
administration at P5 and P6, retinas were analyzed
by isolectin B4 immunostaining at P9. Confocal
images of three different levels (1, 2, 3) within the
whole–mount retinas are shown (right), as indicated.
The preestablished superficial vascular plexus (1) is
not affected, while the extension of perpendicular
endothelial sprouts (2) and vascularization of the
deeper retina (3) are impaired in Jag1iDEC mutants.
Scale bars: A and B: 50 mm; C: 200 mm.
cover capillary beds, make direct cell-
cell contact to ECs and may well affect
sprouting, show no apparent change in
the mutant vasculature (Figures 3G–3L).
Jag1 Overexpression Promotes
Sprouting Angiogenesis
Next, we addressed whether Jagged1
overexpression enhances angiogenesis
in the neonatal retina. To extend the survival of Jag1iGOF mutants
to postnatal stages, tTA activity was suppressed by adminis-
tering tetracycline to pregnant females until E14.5. Like in the
embryonic dermis, upregulated Jag1 expression in the postnatal
endothelium increases vessel branching, EC density, and prolif-
eration (Figures 4A–4E). Likewise, tip cells and filopodia are
significantly more abundant at the Jag1iGOF vascular front
(Figures 4C and 4D).
Immunohistochemistry uncovered notable differences in the
spatial distribution pattern of Jagged1 among ECs. Although
the ligand is readily detectable in stalk cells, expression in tip cells
is low or absent (Figure 4A). This difference is maintained in the
Jag1iGOFvasculature despite elevatedJagged1 levels (Figure 4B).
Jagged1 Inhibits Dll4-Notch Signaling in ECs
Our experimental results suggest that Jagged1 and Dll4 have
opposite effects on sprouting angiogenesis. This could be ex-
plained by Jagged1-mediated inhibition of Dll4-Notch signaling,
even though Jagged1 is known to activate Notch in many cell
types. If Jagged1 actually acts as an antagonist, inactivation of
the gene would upregulate Dll4-Notch signaling in the endothe-
lium. Indeed, the transcriptional repressor Hey1 (Fischer and
Gessler, 2007), a downstream target that is positively regulated
by Notch, is strongly upregulated in the Jag1iDEC endothelium
(Figure 5A). Expression in tips is lower and nuclear Hey1 signal1126 Cell 137, 1124–1135, June 12, 2009 ª2009 Elsevier Inc.
appears confined to stalks and established vessels (Figure 5B).
Thus, even in the Jag1iDEC context, ECs with lower levels of
Notch signaling are sorted to the front, whereas strong Notch
activation (nuclear Hey1) correlates with exclusion from the tip
position.
The related transcriptional repressor Hes1, another Notch
target, is expressed in endothelial, perivascular, and nonvascular
cells (Figures 5C and 5D). Separation of these expression
domains with image processing software uncovers an increase
in Hes1-expressing Jag1iDEC ECs, whereas Hes1+ perivascular
cells are reduced (Figures 5C, 5D, and S3). Dll4 is also positively
regulated by Notch (Ridgway et al., 2006; Shawber et al., 2003;
Figures 6F and 7C), and, accordingly, expression is increased in
Jag1iDEC ECs. Although microvascular expression of Dll4 is nor-
mally higher at the angiogenic front, high levels of the ligand are
found throughout the Jagged1-deficient endothelium (Figure 5E).
Because all three Notch targets tested are upregulated in
Jag1iDECECs, weanalyzed whether Notch inhibition would restore
a wild-type-like response in mutants. The administration of the
g-secretase inhibitor DAPT, which blocks Notch cleavage and
signaling, to control animals induces excessive sprouting, in-
creased EC proliferation, and growth of highly branched network
in the peripheral portion of the retinal vasculature (Hellstrom et al.,
2007; Suchting et al., 2007; Figure 5F). Despite the lowerdensity of
Figure 3. Mural Cell Coverage of Jag1 Mutant Vessels
(A–C) Analysis of the control and Jag1 mutant retinal vasculature
at P6 by whole-mount staining for isolectin B4 (blue), a-smooth
muscle actin (SMA, red), and Desmin (green).
(D–F) Higher magnification of arterioles and venules (bottom insets
in A–C) showing decreased arterial (a) smooth muscle cell
coverage (red fluorescence) in Jag1iDEC mutants. In Jag1null/iDEC
retinas (F), smooth muscle cell coverage of developing arteries
is further reduced, whereas more SMA+ cells are visible on
venules (v).
(G–L) Higher magnification of insets in A–C showing no obvious
alterations in the number and association of Desmin+ pericytes
(green) in proximal, established (G–I) and distal, angiogenic (J–L)
capillaries of Jag1 mutants. Scale bars: A–C: 200 mm; D–L: 50 mm.
Jag1iDEC blood vessels, DAPT triggers a strong sprout-
ing response that is similar to that in DAPT-treated litter-
mate controls (Figure 5F). In more mature blood vessels
of the central retina, where DAPT is able to promote
filopodia formation but not sprouting, DAPT-treated
Jag1iDEC ECs also extend numerous filopodia, compa-
rable to controls (Figure S4). Thus, the chemical inhibi-
tion of Notch confirms that the reduced angiogenic
growth of Jag1iDEC blood vessels is indeed a conse-
quence of increased Notch signaling.
Expression and Function of Fringe Genes
in the Vasculature
Notchsignaling canbe modulated byvariousposttrans-
lational modifications of the receptors, such as the
addition of fucose residues by protein O-fucosyltrans-
ferase 1 (POFUT1) to the extracellular EGF-like repeats,
which can be further modified by Fringe family b-1,3-
N-acetyl-glucosaminyltransferases. Fringe enhances
the activation of Notch in response to Delta-like ligands, but has
the opposite effect for Serrate/Jagged ligands (Yang et al.,
2005). We hypothesized that Fringe-mediated Notch modification
might explain the opposite functional roles of Dll4 and Jagged1 in
ECs, and found that all three mammalian Fringe genes are
expressed in the developing vasculature. In the E10.5 embryo,
Manic Fringe (Mfng) transcripts are abundant throughout the
vasculature, while Lunatic Fringe (Lfng) signals label the dorsal
aorta and cardinal vein (Figure S5). In the postnatal retina, Mfng
expression is found in arteries, veins, and capillary ECs, and
strong signals highlight some stalk as well as established and
newly emerging tip ECs (Figures 6A–6C). Moreover, qPCR on
FACS-sorted GFP-expressing Pdgfb-iCreER (Claxton et al.,
2008) retinal ECs uncovered expression of Radical Fringe (Rfng)
in addition to Lfng and Mfng (Figure 6D). EC markers such as
PECAM1 and Dll4 were enriched 573-fold and 100-fold in these
isolates.
Lfng, Mfng, or Rfng single knockout mice are viable, suggest-
ing redundancy and raising questions about the role of Fringe
genes in the vasculature (Ryan et al., 2008; Zhang et al., 2002).
Nevertheless, our examination of the Lfng/ retinal vasculature
uncovered significantly enhanced sprouting and an increase in
the vascular area (Figure 6E), which indicates reduced Notch
signaling even in the absence of a single Fringe gene.Cell 137, 1124–1135, June 12, 2009 ª2009 Elsevier Inc. 1127
Fringe Modulates Notch Signaling
in a Ligand-Dependent Fashion
Next, we investigated the effect of Fringe (Mfng) modification on
Dll4 and Jagged1-mediated signaling in cultured mouse ECs, for
which qPCR shows low baseline Fringe expression. Stimulation
with immobilized Dll4 or Jagged1 proteins, which can activate
Notch in a cell contact-independent fashion (Li et al., 2007),
leads to the upregulation of the target genes Hes1, Hey1, and
Dll4, although to different extent (Figure 6F). In response to
Mfng overexpression, Dll4 becomes more potent in activating
Notch targets, consistent with previous findings for the related
ligand Delta-like 1 in other cell types (Yang et al., 2005). In
Mfng-overexpressing ECs, Jagged1 can induce only weak
responses barely above the background of control-treated cells.
Combining the recombinant Dll4 and Jagged1 used for the
Figure 4. Endothelial Jagged1 Promotes
Sprouting Angiogenesis
(A and B) Retinas from control (tetO-Jag1) and
Jag1 gain-of-function (Jag1iGOF, i.e., tetO-Jag1 3
Vecad-tTA) P6 pups were stained for isolectin B4,
Jagged1, and Topro3 as indicated. Increased
Jagged1 expression in retinal capillaries (B)
enhances vessel branching and EC density. Arteri-
oles (a) and venules (v) are indicated. Bottom
panels show Jagged1 distribution in single ECs,
which were identified by IsolB4 (red) and nuclear
Topro3 staining (blue or pink). Individual ECs were
separated by white lines and nuclei marked with
white dots for analysis. Numbers indicate average
intensity level of anti-Jagged1 staining per EC. Tip
cells have low or no Jagged1, while stalk cell
expression is higher in control and Jag1iGOF retinas.
(C) Isolectin B4 immunofluorescence showing
increased tip cell and filopodia extension at the
Jag1iGOF angiogenic front.
(D) Quantitation of branch points, EC area, tip cell
and filopodia numbers in control and Jag1iGOF
retinas.
(E) Isolectin B4 (red) and BrdU labeling (green) of
control and Jag1iGOF P6 retinas (left) and quantita-
tion of BrdU+ ECs (right) per field or normalized
relative to EC coverage, as indicated. Error bars
represent s.e.m.; P values are indicated. Scale
bars: A and B upper panel: 80 mm; A and B lower
panel: 25 mm; C: 17 mm; E: 50 mm.
individual stimulation experiments leads
to an intermediate response, which con-
firms that Jagged1 can antagonistically
interfere with Dll4-Notch interactions
(Figure 6F).
We also investigated the activity of Dll4
and Jagged1 in coculture assays by mix-
ing signal-sending (ligand-presenting)
and Notch1 reporter cell lines, only the
latter of which contain a (Rbpj)6-luciferase
Notch reporter construct (Geffers et al.,
2007). Expression of Mfng in Notch1 cells
strongly enhances reporter activation by
Dll4 cells, whereas Mfng expression has
little effect in ligand-presenting cells (Figure 6G, columns 1–6).
Similar to the trans-inhibition observed with immobilized
Jagged1 and Dll4 proteins, coexpression of Jagged1 and Dll4
in ligand cells strongly reduces the activation of (Rbpj)6-luciferase
in adjacent Mfng-expressing Notch1 reporter cells compared to
Dll4 alone (Figure 6G, columns 6 and 7). Expression of the two
ligands in separate cell populations (i.e., Dll4 in signal-sending
and Jagged1 in Mfng+ Notch1 reporter cells) also reduces
luciferase expression (Figure 6G, columns 6 and 8). While this
effect might hint at Jagged1-mediated cis-inhibition of Notch in
this assay, (Rbpj)6-luciferase activation was enhanced and not
inhibited by Jagged1 when Notch1 cells lacked Mfng (Figure 6G,
compare columns 1 and 9). Both in vitro assays indicate that
Jagged1 is a productive (agonistic) ligand when Notch1 is not
Fringe-modified, but is rendered into an antagonist that1128 Cell 137, 1124–1135, June 12, 2009 ª2009 Elsevier Inc.
competes with the more signaling-competent Dll4 ligand when
Notch is glucosaminylated. Accordingly, (partial) siRNA-medi-
ated knockdown of Fringe gene expression in cultured human
ECs reduces Dll4-mediated Notch signaling, whereas Jagged1
becomes a more potent activator (Figure S5).
Jag1 and Dll4 in the Angiogenic Growth Program
To understand the interplay between the two ligands during EC
sprouting, we have analyzed the spatial distribution of Jagged1
and Dll4 in the retina. As previously shown, Dll4 is enriched at
the angiogenic front and labels tip ECs as well as a fraction of
stalk cells (Claxton and Fruttiger, 2004; Hellstrom et al., 2007;
Hofmann and Luisa Iruela-Arispe, 2007; Lobov et al., 2007). In
contrast, anti-Jagged1 immunostaining is weak or absent in
tip cells but very prominent in adjacent stalk ECs (Figures 7A
Figure 5. Jagged1 Inhibits Dll4-Notch
Signaling in Endothelial Cells
(A) Whole-mount immunofluorescence showing
upregulated Hey1 protein in the P6 Jag1iDEC retinal
vasculature.
(B) Hey1 localization (green) in the angiogenic
Jag1iDEC retinal endothelium (IsolB4, red). Higher
magnification of inset (center) and corresponding
channel with Hey1 signal (right) are shown. Note
pronounced expression and nuclear localization
(arrows) of Hey1 in stalk ECs (numbers indicate
signal intensity level), whereas specific signal is
weak or absent in filopodia-extending tip cells
(T1, T2).
(C) Whole-mount triple immunofluorescence
(IsolB4, blue; Jagged1, red; Hes1, green) of P6
control and Jag1iDEC retinas.
(D) Analysis of Hes1 expression in higher magnifi-
cation pictures of insets in (C). Cells with high anti-
Hes1 signal are boxed in yellow for IsolB4+ ECs
(blue) and in red for non-ECs. The number of
Hes1+ ECs is increased in Jag1iDEC mutants,
whereas fewer Hes1+ perivascular and nonvas-
cular cells can be seen.
(E) Whole-mount triple immunofluorescence for
the indicated antigens showing upregulated Dll4
expression in the Jag1iDEC endothelium.
(F) Isolectin B4–stained P7 retinas from control and
Jag1iDEC littermates. Injection of vehicle (upper
panels) does not affect branching. Administration
of DAPT for 40 hr before dissection (lower panels)
triggers enhanced EC sprouting and formation of
a dense, hyperfused plexus in the distal control and
Jag1iDEC retinal endothelium. Scale bars: A and
F: 200 mm; B: 70 mm and 18 mm; D: 25mm; E: 50mm.
and 7B). Since our findings have estab-
lished that the Jag1 and Dll4 genes have
complementary functional roles, one
would predict that angiogenesis can be
modulated by upstream signals that regu-
late these two ligands differentially. For
example, cell contact–mediated Notch
activation upregulates the expression of
Dll4 in cultured mouse or human ECs but
has no effect on Jag1 transcript levels (Figures 7C and S6A).
Conversely, tumor necrosis factor-a (TNF-a), a proinflammatory
cytokine, reduces Dll4 but increases Jag1 expression (Sainson
et al., 2008; Figure 7C).
Previous work has uncovered that Notch activation downregu-
lates the expression of proangiogenic VEGF receptors, namely
VEGFR-2 and VEGFR-3 (Hellstrom et al., 2007; Suchting et al.,
2007; Tammela et al., 2008), which could help to dampen
down tip-like sprouting activity in stalk cells. We observed that
Jag1 inactivation in postnatal ECs leads to strongly reduced
expression of VEGFR-3 at the angiogenic front in the retina
(Figure 7D), which provides a direct mechanistic explanation
for impaired sprouting and EC proliferation in Jag1iDEC mutants.
Low or absent Notch activity leads to upregulated VEGF recep-
tor expression, and, accordingly, Notch1- or Rbpsuh-deficientCell 137, 1124–1135, June 12, 2009 ª2009 Elsevier Inc. 1129
Figure 6. Mfng Modulates Endothelial Notch Signaling by Jag1 and Dll4
(A–C) Whole-mount immunofluorescence for Isolectin B4 in the P6 retina in combination with fluorescent in situ hybridization for Mfng as indicated. (A) Mfng is
expressed in arterioles (a), venules (v), and a subset of capillary ECs. (B and C) Mfng transcripts in the angiogenic front tip (arrows in B). Strongest staining high-
lights subsets of both stalk and tip cells (arrows in C).
(D) qRT-PCR analysis of PECAM1, Dll4, Lfng, Rfng, and Mfng expression in FACS-sorted ECs (0.06% of total cells) from the P9 retina.
(E) Confocal images showing increased vessel branching and high EC coverage in isolectin B4–stained Lfng-deficient P4 retinas (left panels) and quantitation of
tip cell number and EC area in comparison to wild-type littermates (right panels).
(F) Quantitative RT-PCR analysis of Hes1, Hey1, and Dll4 mRNAs from cultured control (left) or Mfng-overexpressing mouse ECs (right) following stimulation with
immobilized recombinant Dll4, Jagged1, or a mixture (1:1) of both ligands. Expression of mouseGapdhwas used as control and changes were calculated relative
to unstimulated cells.
(G) Notch coculture assay. Modulation of (Rbpj)6-luciferase activity in Notch1 (reporter) cells mixed with signal-sending (ligand) cells stably expressing Dll4.
Effects of transient expression of Mfng or Jagged1 in reporter or ligands cells are shown, as indicated (n = 5). Equal expression levels of Jagged1 were confirmed
by Western blot analysis. Scale bars: A: 100 mm; B: 50 mm; C: 22 mm; E: 200 mm and 77 mm. p values are < 0.05 (*), < 0.01 (**), or not significant (-).ECs preferentially formed tip cells when mosaic experiments
were performed in mouse or zebrafish (Hellstrom et al., 2007;
Siekmann and Lawson, 2007). Consistent with the concept that
coexpression of Jagged1 in tips would impair the ability of Dll4
to signal to stalk cells, Jag1-deficient ECs expressing a fluores-
cent protein Cre reporter are preferentially found at the tip
position in mosaic mutants induced with a low dose of tamoxifen
(Figure 7E). On the other hand, ECs with higher Jagged1 levels
are preferentially sorted to the stalk in the Jag1iGOF retinal vascu-
lature (Figures 4A and 4B). The sum of all our results delineates
a molecular pathway of tip cell selection that is controlled by
the interplay of two Notch ligands, Dll4 and Jagged1.1130 Cell 137, 1124–1135, June 12, 2009 ª2009 Elsevier Inc.DISCUSSION
Dll4 and Jagged1 Control Tip Cell Selection
Angiogenesis requires a tightly coordinated balance between EC
sprouting and the maintenance of existing vascular tubes. Pre-
vious work has shown that this equilibrium can be controlled
by Dll4 expression in endothelial tip cells, which activates Notch
signaling and thereby suppresses sprouting in adjacent ECs.
Accordingly, impaired Dll4/Notch expression or function leads
to excessive but nonproductive sprouting because too many
ECs respond to proangiogenic growth factors such as VEGF.
However, the spatial expression pattern of Dll4 is not fully
Figure 7. Regulation of Sprouting Angio-
genesis by Dll4 and Jagged1
(A and B) Triple whole-mount immunofluores-
cence for Dll4 (red), Jagged1 (green), and isolectin
B4 (blue) at the angiogenic front of P6 retinas. (B)
Higher magnification of the inset in (A). Individual
channels and merged images are shown as indi-
cated. While Dll4 expression is high in tip cells
and also visible in adjacent stalk ECs at the edge
of the growing plexus, Jagged1 expression is
low/absent in tips but abundant in adjacent stalk
cells and capillaries. Yellow dots are autofluores-
cent blood cells.
(C) qRT-PCR analyses of Hes1, Hey1, Dll4, and
Jag1 mRNAs in mouse ECs (MECs) cultured at
low density (1:10) or in confluent conditions in
the presence or absence of DAPT (left). Changes
in Hey1, Dll4, and Jag1 transcripts following stim-
ulation of human ECs (HUVECs) with TNF-a for
6 hr (right).
(D) Whole-mount isolectin B4 (blue) and VEGFR-3
(red) staining of P6 control and Jag1iDEC retinas.
(E) Mosaic analysis showing correlation between
Cre reporter (green, YFP) activation and EC sort-
ing. YFP+ (green asterisk) and YFP (red asterisk)
tips are indicated. Quantitation (right) shows that
Jag1-deficient but not control ECs more often
become tips relative to their total proportion.
(F) Proposed model for the modulation of Dll4-
Notch signaling by Jagged1 (left) and alterations
in the Jag1 and Lfng mutant vasculature (right).
VEGF signaling in tip cells induces (+) the expres-
sion of Dll4. Fringe modification of Notch (most
probably Notch1; N1) in stalk ECs enhances
Notch signaling by Dll4-presenting tip cells, which
reduces VEGF receptor expression and maintains
the stalk phenotype. Dll4 is antagonized by
Jagged1, which promotes angiogenesis and
increases tip cell numbers by lowering Notch acti-
vation levels, while VEGF signaling is enhanced.
Angiogenic sprouting might be positively (+) or
negatively () modulated by differential regulation
of Jagged1 and Dll4 in endothelial cells as well as
in adjacent nonendothelial cells, such as tumor
cells. TNF-a upregulates (+) Jag1 but lowers ()
Dll4 transcript levels. Dll4 but not Jag1 is induced
by Notch signaling. Jagged1 in stalk cells prevents
that coexpressed Dll4 can activate Notch in
neighboring (stalk or tip) ECs. This activity of
Jagged1 depends on Fringe, which reduces Notch activation by Jagged1 and thereby leads to competition between a strong agonist (Dll4) and antagonistically
acting Jagged1. All these processes are presumably highly dynamic. Scale bars: A: 25 mm; B: 6 mm; D: 65 mm; E: 45 mm.compatible with a simple tip-to-stalk signaling interaction. Our
study identifies Jagged1 as a further critical component in the
process of tip cell selection. In contrast to Dll4, Jagged1 is
proangiogenic and functions by downregulating Dll4-Notch
signaling. We propose that this is of particular importance in stalk
cells, where Jagged1 levels are high and will therefore efficiently
antagonize the more potent Dll4 ligand (Figure 7F). As a
consequence, stalk cells should have little ability to activate
Notch in adjacent tip cells. Jagged1 also counteracts Dll4-Notch
signaling interactions between stalk ECs, which helps to sustain
elevated VEGF receptor expression in the freshly formed and
therefore immature vascular plexus at the angiogenic front.Thus, ECs in this region can still respond to VEGF, which, in
turn, promotes proliferation as well as the dynamic emergence
of new tip cells.
The Role of Fringe Glycosyltransferases
Our data suggest that the expression of Fringe glucosaminyl-
transferases is highly relevant in the growing vasculature. Loss
of Lfng enhances angiogenic sprouting in the retinal endothelium
despite the expression of Rfng and Mfng. We propose that
Fringe-mediated modification of Notch critically controls tip
cell selection in at least two different ways. First, Notch activation
in response to Dll4 binding is enhanced, which will amplify theCell 137, 1124–1135, June 12, 2009 ª2009 Elsevier Inc. 1131
ability of tip cells to signal to adjacent stalk ECs. In addition,
Fringe modification will reduce Notch activation upon Jagged1
binding so that Jagged1 effectively acts as an antagonist, which
competes with Dll4 and thereby locally enhances angiogenic
growth. Although Notch ligands can be also modified by Fringe
glycosyltransferases (Panin et al., 2002), our coculture assays
indicate that receptor modification is critical, whereas coexpres-
sion of Mfng and Notch ligands has relatively minor effects on
Notch activation (Figure 6G).
Given the important role of Fringe molecules in the regulation
of angiogenesis, understanding the upstream signals controlling
Mfng, Lfng, and Rfng expression and activity should be of great
importance.
Alternative Mechanisms of Jagged1 Activity?
Despite the evidence that Jagged1 predominantly acts by
blocking Dll4-Notch interactions, it is useful to consider putative
alternative mechanisms. For example, Jagged1 might trigger
so-called ‘‘noncanonical’’ Notch signaling that does not involve
RBP-J, the key downstream signaling partner of Notch (Le Gall
et al., 2008), and therefore might not affect the normal Notch
target genes. However, the upregulation of Notch targets in the
Jag1iDEC endothelium and the reversal of the mutant phenotype
by Notch inhibition show that Jagged1 strongly modulates
‘‘canonical’’ Dll4-Notch signaling.
Several studies have proposed that Delta-like/Delta and
Jagged/Serrate ligands can inhibit signaling by coexpressed
Notch in a cell-autonomous fashion, termed cis-inhibition (Glit-
tenberg et al., 2006). Although Notch cis-inhibition may occur
in ECs, our in vitro signaling assays and the expression of
Jagged1 in stalk cells argue that the ligand predominantly
inhibits Dll4-Notch signaling in a non-cell-autonomous fashion
(i.e., by binding to Notch receptors on adjacent cells). Cis-inhibi-
tion of Notch by Jagged1 in stalk cells would impair the effect of
Dll4 presented by tip cells and compromise essential tip-to-stalk
signaling. For the same reason, Jagged1 reverse signaling,
a process that would involve ligand cleavage and release of
a cytoplasmic, Notch-inhibiting fragment (LaVoie and Selkoe,
2003; Six et al., 2003) cannot explain our findings. Stimulation
of cultured ECs with immobilized, recombinant Notch1 fusion
protein also has no appreciable effect on Notch target genes
(Figure S6).
Differential Regulation of Dll4 and Jagged1
Given that Dll4 and Jagged1 have opposing roles in endothelial
sprouting, upstream signals controlling the expression of one or
the other ligand might modulate angiogenesis positively or nega-
tively. While VEGF has been shown to induce the expression of
Dll4 in ECs (Hainaud et al., 2006; Lobov et al., 2007; Noguera-
Troise et al., 2006), Jagged1 is absent in tip cells, which are
exposed to the highest levels of VEGF, suggesting that the two
ligands might be regulated differentially. Notch signaling is
another positive regulator of Dll4 but not of Jagged1, whereas
the inflammatory (and, in some settings, proangiogenic) cytokine
TNF-a upregulates Jag1 but reduces Dll4 transcript levels.
Thus, these and other signals might modulate angiogenesis by
changing the ratio of Jagged1 and Dll4 expression. The existence
of two Notch ligands with opposing roles and differential regula-1132 Cell 137, 1124–1135, June 12, 2009 ª2009 Elsevier Inc.tion allows the integration of different pro- or antiangiogenic
signals into a single biological process, the selection of endothe-
lial tip cells. Moreover, Notch pathway components such as Delta
ligands and Lfng can be expressed in an oscillatory manner
(Kageyama et al., 2007), which could provide an appealing expla-
nation for the regulation of dynamic and repetitive processes
such as endothelial sprouting.
Jagged1 and Notch Signaling in Other Tissues
Delta-like/Delta and Jagged/Serrate ligands have different bio-
logical roles in many organs and tissues, for example in the
developing nervous and immune systems (Amsen et al., 2004;
Brooker et al., 2006), which has been attributed to spatiotem-
poral differences in ligand expression or the cellular context of
Notch activation. Because Fringe proteins are well-established
modulators of Notch signaling (Bray, 2006; Kageyama et al.,
2007), Jagged/Serrate ligands might act more frequently as
antagonists of Fringe-amplified Delta-Notch signaling. Thus,
our findings may have much broader relevance for the many
other cell types, tissues, and biological processes that are regu-
lated by the Notch pathway.
Therapeutic Potential of Dll4 and Jagged1 Inhibition
Several studies have found that the inhibition of Dll4 leads to
enhanced but nonproductive endothelial sprouting, poor perfu-
sion, and reduced growth of experimental tumors, which might
prove particularly useful for tumors that are resistant against
anti-VEGF therapy (Li et al., 2007; Noguera-Troise et al., 2006;
Ridgway et al., 2006). Conversely, expression of Dll4 in tumor
cells can block sprouting from tumor blood vessels, presumably
by suppressing emerging tip cells. The remaining vasculature,
however, lacks the fragility and leakiness of typical tumor blood
vessels and gives good access to oxygen (Li et al., 2007;
Noguera-Troise et al., 2006). Because of the links between Dll4-
Notch signaling and the VEGF pathway, Dll4-expressing cancers
might be more resistant to anti-VEGF therapy.
Little is known about the role of Jagged1 in tumor vessels, but
overexpression of the ligand in cancer cells has been shown to
promote neovascularization and the growth of experimental
tumors in mice (Zeng et al., 2005). These results are consistent
with the proangiogenic activity of Jagged1 during developmental
angiogenesis. If intratumor ECs express Fringe molecules,
Jagged1 might reduce Notch signaling and thereby enhance
responses to growth factors such as VEGF. It is feasible that
such tumors are more susceptible to VEGF inhibition or other
antiangiogenic treatments. In other pathological situations
where angiogenesis is deregulated, selective inhibition of Dll4
or Jagged1 might allow the transient enhancement or suppres-
sion of blood vessel growth. The benefit of such treatments will
have to be explored in future work.
EXPERIMENTAL PROCEDURES
Mutant Mice and Inducible Genetic Experiments
To delete Jag1 in ECs,Tie1-Cre transgenics (Gustafsson et al., 2001) were bred
into a background of Jag1floxed/floxed mice (Brooker et al., 2006), and embryos
were analyzed at different stages. For postnatal EC-specific loss-of-function
experiments, Pdgfb-iCreER (Claxton et al., 2008) Jag1floxed/floxed or Pdgfb-
iCreER Jag1KOnull/floxed males were mated with Jag1floxed/floxed females. Gene
inactivation in pups was triggered by intraperitoneal injection of 50 ml of
tamoxifen solution (Sigma, T5648; 1 mg/ml; generated by diluting a 10 mg/ml
tamoxifen stock solution in 1:4 ethanol:peanut oil with peanut oil) once daily
at P1, P2, and P3 or at P5 and P6, respectively.
For the overexpression of Jag1 in ECs, a single copy of the full-length murine
Jag1 cDNA coupled to a tetracycline-responsive minimal promoter (Gossen
and Bujard, 1992) was introduced into embryonic stem (ES) cells by targeted
integration into the X-linked HPRT locus. Blastocyst injection of validated ES
cell clones yielded tetO-Jag1 transgenic mice, which were bred to VE-Cad-
herin-tTA transgenics (Sun et al., 2005). To avoid lethality triggered by Jagged1
overexpression in the embryonic endothelium, pregnant females were given
tetracycline (1 mg/ml) in the drinking water from E1.5 to E14.5.
Notch signaling was inhibited in some pups injected with tamoxifen from P1
until P3 by intraperitoneal injection of 0.2 mg/g N-[N-(3,5–Difluorophenacetyl-
L-alanyl)]-S-phenylglycine t-butyl ester (DAPT; Calbiochem) dissolved in 10%
ethanol and 90% peanut oil. DAPT solution was injected twice at P5 and P6,
and retinas were collected 40 hr later at P7. Control mice were injected with
vehicle only.
For mosaic deletion of Jagged1 in the retina, Jag1floxed/floxed were combined
with VE-Cadherin(PAC)-CreERT2 (R.H.A., unpublished data) and Rosa26
EYFP Cre reporter (Srinivas et al., 2001) transgenes. P4 Jag1 mutant and
control CreERT2+ and Rosa26 EYFP+ pups received one intraperitoneal injec-
tion of 25 ml of tamoxifen solution (1 mg/ml), and retinas were collected 48 hr
later for analysis.
To study the role of the Lfng gene in the retinal vascular development,
Lfng+/ mice (Zhang and Gridley, 1998) were interbred. Lfng/ and +/+
retinas were isolated and analyzed at P4. Animal experiments comply with
the relevant laws and were approved by local animal ethics committees.
Immunohistochemistry and In Situ Hybridization
Embryos were dissected in PBS and fixed in 4% paraformaldehyde (PFA)
overnight, and skin from the head region was used for whole-mount immuno-
staining, as described previously (Foo et al., 2006). Retinas for double or triple
whole-mount immunohistochemistry were fixed in 4% PFA overnight at 4C,
2 hr on ice in PFA 2%, or in MeOH at 20C. After fixation, retinas were incu-
bated in 1% BSA and 0.3% Triton, washed three times in Pblec buffer (1%
Triton X-100, 1 mM CaCl2, 1 mM MgCl2, and 1 mM MnCl2 in PBS [pH 6.8]),
and incubated overnight in Pblec containing biotinylated isolectin B4 (1:25,
VectorLabs). The following primary antibodies were diluted in 1% BSA and
0.3% Triton and incubated overnight: PECAM1 (1:100, PharMingen), GFP
(1:500, Molecular Probes), Hey1 (1:200, Chemicon), Hes1 (1:200, Santa
Cruz), Dll4 (1:200, R&D Systems), Jagged1 H114 (1:200, Santa–Cruz), collagen
IV (1:200, Chemicon), VEGFR-3 (1:100, R&D Systems), aSMA-CY3 (Sigma),
and desmin (1:500, Abcam). For secondary detection, Alexa Fluor streptavidin
conjugates (Molecular Probes, 1:100) or species-specific Alexa Fluor–coupled
secondary antibodies (1:500) were used. Cell nuclei were visualized with
TO-PRO 3 (Molecular Probes, 1:1000).
For labeling of proliferating cells, 300 mg of BrdU per pup was injected intra-
peritoneally 2 hr before sacrifice. Following isolectin B4 staining, retinas were
fixed for 30 min in 4% PFA, washed 3 times with PBS, incubated for 1 hr in
6 M HCl and 0.1% Triton X-100, washed 5 times in PBS plus 0.1% Triton
X-100, blocked, and incubated overnight with anti-BrdU antibody (1:50, BD
PharMingen). Secondary detection was performed with Alexa Fluor-coupled
secondary antibodies.
Whole-mount in situ hybridization was performed as published previously
(Claxton and Fruttiger, 2004; Myat et al., 1996). A linearized murine Mfng
cDNA was used for the transcription of a digoxigenin-labeled anti-sense ribo-
probe. Whole eyes were fixed for 2 hr on ice in 4% PFA and stored in Methanol
at 20C. Bound riboprobes were visualized with anti-digoxigenin antibody
conjugated to alkaline phosphatase (1:2000, Roche) and Fast Red tablets
(Roche). Afterward, retinas were fixed for 1 hr and immunostained with biotiny-
lated isolectin B4.
Stained and flat mounted retinas were analyzed with a Leica TCS SP5
confocal microscope. In situ hybridization for the detection of Mfng or Lfng
transcripts in tissue cryosections was performed as described previously
(Myat et al., 1996), but with Fast Red tablets (Roche) for the visualization of
digoxigenin-labeled riboprobes.EC Isolation, Culture, and qRT-PCR
For the stable overexpression of murine Mfng, the full-length cDNA was
inserted into the pBABE-puro retroviral construct. pBABE-puro (control) or
the pBABE-puro-Mfng constructs were transfected into Phoenix packaging
cells, and the virus-containing supernatant of these cells was used to infect
immortalized mouse ECs (see Supplemental Experimental Procedures).
Stable expressing clones were obtained by selection with 12.5 mg/ml puro-
mycin. qRT-PCR revealed a 125-fold upregulation of Mfng transcripts,
compared with the low baseline expression in control cells.
For Notch stimulation with recombinant ligands, 6-well plates were incu-
bated with anti-Fc (Jackson), anti-His (Zymed), or a 1:1 mixture of both anti-
bodies (6.48 mg/ml) for 30 min at 37C. Plates were washed with PBS and
blocked for 1 hr at 37C with 10% FCS in DMEM. Recombinant Notch1-Fc
(R&D, #1057-TK), Dll4 (mouse Dll4-His R&D; #1389-D4), or Jagged1 (rat
Jag1-Fc, R&D #599–JG), diluted in PBS to a concentration of 18 nM, or a
1:1 mixture of both ligands were added (700 ml/well) and incubated for 2 hr at
37C and washed; 3.5 3 105 cells/well control or Mfng-overexpressing ECs
were plated and left for 8 hr at 37C.
TNF-a stimulations of HUVECs were done with 2 ng/ml for 6 hr. To inhibit
Notch signaling in vitro, MECs or HUVECs were treated with 10 mM DAPT.
To block Fringe expression in cultured cells, transfection with combined
100 nM smartpool siRNAs for Mfng, Rfng, and Lfng (Dharmacon) or 300 nM
control siRNA was performed according to the manufacturer’s instructions.
After 48 hr, cells were detached by trypsinization and stimulated with recombi-
nant Dll4 or Jagged1 ligands as described above.
For the analysis of gene expression, total RNA was isolated with the RNAeasy
mini kit (QIAGEN), and 500 ng/reaction were used to generate cDNA with the
SuperScriptTM III First-Strand Synthesis System for RT-PCR (Invitrogen) and
oligo(dT) primers. qPCR was performed in triplicate by using an ABI PRISM
7900HT and Power SYBR green Master Mix (Applied Biosystems). Gene expres-
sion was normalized to Glyceraldehyde 3-phosphate dehydrogenase (Gapdh).
The relative expression differences represent the average of 3 independent stim-
ulation experiments. Two separate qPCRs with triplicate reactions for each gene
and condition were performed (see Supplemental Data for primer details).
For the isolation of retinal ECs, retinas from P9 Pdgfb-iCreER (Claxton et al.,
2008) pups were dissected and dissociated with the Papain dissociation
system (Worthington). GFP + and GFP cells were separated with the
FACSAria Cell-Sorting System (BD Biosciences) and collected in lysis buffer,
and total RNA was extracted with the RNAeasy Mini Kit (QIAGEN).
Transactivation (Coculture) Notch Assay
CHO cells stably expressing Dll4 were transiently transfected with Jag1 and or
Mfng expression plasmids using jetPEI DNA transfection reagent following the
manufacturer’s instructions. HeLa cells stably expressing Notch1 (Minoguchi
et al., 1997) were transiently transfected with Jag1 and/or Mfng expression
plasmids and the RBP–luciferase reporter (Minoguchi et al., 1997) construct;
1 3 106 transfected HeLa reporter cells were cocultivated with 1 3 106 CHO
ligand cells in 6-well plates for 24 hr. Luciferase activity was measured using
the Dual-Luciferase reporter Assay System (Promega). Firefly luciferase
activity was normalized to cotransfected Renilla luciferase (phRL-TK, Prom-
ega). Equal levels of transient Jagged1 expression were validated by western
blot. Reporter activation by untransfected parental CHO cells was taken as
baseline and subtracted from each data point.
Statistics and Image Processing
Volocity (Improvision), Photoshop CS, and Illustrator CS (Adobe) software
were used for image processing in compliance with the ‘‘Cell Press Data Pro-
cessing Policy.’’ Data are based on a minimum of three independent experi-
ments or three mutant and control animals for each stage and result shown.
Methods for the quantitative analysis of the retinal vasculature are provided
in the Supplemental Experimental Procedures.
SUPPLEMENTAL DATA
Supplemental data include Supplemental Experimental Procedures and seven
figures and can be found with this article online at http://www.cell.com/
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